Deva Holding AS (DEVA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.058x

Based on the latest financial reports, Deva Holding AS (DEVA) has a cash flow conversion efficiency ratio of 0.058x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL1.53 Billion ≈ $34.34 Million USD) by net assets (TL26.48 Billion ≈ $593.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Deva Holding AS to measure how much of total assets are equity-financed.

Deva Holding AS - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Deva Holding AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Deva Holding AS cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Deva Holding AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Deva Holding AS ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Surya Permata Andalan Tbk PT JK:NATO	0.005x
Gérard Perrier Industrie S.A. PA:PERR	0.163x
Wave Cyber Shanghai Co Ltd SHG:688718	0.028x
Tanzanian Royalty Exploration Corp NYSE MKT:TRX	0.039x
Zentalis Pharmaceuticals Llc NASDAQ:ZNTL	-0.143x
SBC Medical Group Holdings Incorporated NASDAQ:SBC	0.251x
Camil Alimentos S.A SA:CAML3	0.102x
Jilin Jian Yisheng Pharmaceutical Co Ltd SHE:002566	0.003x

Annual Cash Flow Conversion Efficiency for Deva Holding AS (2005–2024)

The table below shows the annual cash flow conversion efficiency of Deva Holding AS from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see DEVA stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	TL20.81 Billion ≈ $466.11 Million	TL5.07 Billion ≈ $113.50 Million	0.243x	-27.39%
2023-12-31	TL21.34 Billion ≈ $478.04 Million	TL7.16 Billion ≈ $160.30 Million	0.335x	+61.80%
2022-12-31	TL3.94 Billion ≈ $88.17 Million	TL815.91 Million ≈ $18.27 Million	0.207x	-54.69%
2021-12-31	TL2.73 Billion ≈ $61.10 Million	TL1.25 Billion ≈ $27.95 Million	0.457x	+15.74%
2020-12-31	TL1.63 Billion ≈ $36.61 Million	TL645.98 Million ≈ $14.47 Million	0.395x	-7.66%
2019-12-31	TL1.03 Billion ≈ $23.09 Million	TL441.24 Million ≈ $9.88 Million	0.428x	+143.91%
2018-12-31	TL746.41 Million ≈ $16.72 Million	TL130.98 Million ≈ $2.93 Million	0.175x	-4.20%
2017-12-31	TL605.09 Million ≈ $13.55 Million	TL110.84 Million ≈ $2.48 Million	0.183x	-49.88%
2016-12-31	TL512.85 Million ≈ $11.49 Million	TL187.44 Million ≈ $4.20 Million	0.365x	+86.96%
2015-12-31	TL453.11 Million ≈ $10.15 Million	TL88.58 Million ≈ $1.98 Million	0.195x	+56.38%
2014-12-31	TL411.91 Million ≈ $9.23 Million	TL51.49 Million ≈ $1.15 Million	0.125x	+0.69%
2013-12-31	TL403.05 Million ≈ $9.03 Million	TL50.04 Million ≈ $1.12 Million	0.124x	+618.95%
2012-12-31	TL378.63 Million ≈ $8.48 Million	TL6.54 Million ≈ $146.43K	0.017x	-67.04%
2005-12-31	TL114.50 Million ≈ $2.56 Million	TL6.00 Million ≈ $134.34K	0.052x	--

About Deva Holding AS

IS:DEVA Turkey Drug Manufacturers - Specialty & Generic

Market Cap

$314.04 Million

TL14.02 Billion TRY

Market Cap Rank

#14435 Global

#142 in Turkey

Share Price

TL70.10

Change (1 day)

-3.31%

52-Week Range

TL59.00 - TL80.65

All Time High

TL102.39